Advanced Biomed Inc. (NASDAQ:ADVB) Short Interest Update

Advanced Biomed Inc. (NASDAQ:ADVB) saw a significant growth in short interest in June. As of June 15th, there was short interest totaling 8,876 shares, a growth of 356.3% from the May 31st total of 1,945 shares. Based on an average trading volume of 35,930 shares, the short-interest ratio is presently 0.2 days. Approximately 0.7% of the company’s shares are short sold.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, June 23rd. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.

Advanced Biomed Price Performance

ADVB stock opened at $4.49 on Monday. The business’s 50 day simple moving average is $4.83. Advanced Biomed has a 52-week low of $3.61 and a 52-week high of $18.20. The stock has a market cap of $7.41 million, a P/E ratio of 0.93 and a beta of 0.68.

Advanced Biomed (NASDAQ:ADVB) last released its earnings results on Friday, May 15th. The company reported ($0.38) EPS for the quarter.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.